Orange Book product · Brand (NDA)
ONMEL
ITRACONAZOLE
At a glance
Apr 29, 2010
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 29, 2010
16 yr 5 mo ago
Today
Patent 8486456 expires
Listed drug product patent expiration.
Oct 03, 2028
in 2 yr 4 mo
Pharmaceutical detail
Active ingredient
ITRACONAZOLE
Strength
200MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 022484
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2018TOLSURABrand (NDA)
NDA 208901 · MAYNE PHARMA
- 1999SPORANOXBrand (NDA)
NDA 020966 · JANSSEN PHARMS
- 1997SPORANOXBrand (NDA)
NDA 020657 · JANSSEN PHARMS
- 1992SPORANOXBrand (NDA)
NDA 020083 · JANSSEN PHARMS
- 2020ITRACONAZOLEGeneric (ANDA)
ANDA 212239 · ANNORA PHARMA
- 2019ITRACONAZOLEGeneric (ANDA)
ANDA 208481 · APOTEX
- 2019ITRACONAZOLEGeneric (ANDA)
ANDA 206410 · STRIDES PHARMA
- 2018ITRACONAZOLEGeneric (ANDA)
ANDA 209460 · TORRENT
- 2017ITRACONAZOLEGeneric (ANDA)
ANDA 204672 · ZYDUS PHARMS
- 2017ITRACONAZOLEGeneric (ANDA)
ANDA 208591 · ALKEM LABS LTD
- 2017ITRACONAZOLEGeneric (ANDA)
ANDA 203445 · JUBILANT GENERICS
- 2016ITRACONAZOLEGeneric (ANDA)
ANDA 206741 · ALEMBIC
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8486456 | Oct 03, 2028 | in 2 yr 4 mo | ProductU-1054 |

